期刊文献+

甲状腺乳头状癌与相关基因的研究进展 被引量:9

Progress of papillary thyroid cancer and its related genes
原文传递
导出
摘要 甲状腺癌是临床十分常见的恶性肿瘤,约占所有内分泌肿瘤的95%。全世界每年平均甲状腺癌发病122 000例,已成为头颈部和内分泌肿瘤中发病率和死亡率最高的疾病。甲状腺癌的发病率呈逐年上升的趋势,对人类健康构成了严重威胁。在甲状腺癌的分型中,甲状腺乳头状癌(PTC)约占所有甲状腺癌的80%,其发病率远高于其他病理类型。文章主要对PTC的发生、发展以及预后相关基因研究进展进行综述。 Thyroid cancer is a very common malignancy, accounting for about 95% of all endocrine tumors. According to reports in the literature, 122 000 cases of thyroid cancer each year in the world have become the disease with the highest morbidity and mortality in head and neck and endocrine tumors. The incidence of thyroid cancer is still growing, posing a serious threat to human health. Papillary thyroid carcinoma(PTC) accounts for about 80% of all thyroid cancer, the incidence is much higher than other pathological types. This review focuses on the advances of PTC, including its occurrence, development and prognosis related genes.
作者 孙蕾 潘新宇 赵玉 于建渤 Sun Lei;Part Xinyu;Zhao Yu;Yu Jianbo(Pathology Teaching and Research Office,Mudanjiang Medical University,Mudanjiang 157011,China;Pathology Center Mudanjiang Medical University Affiliated Hongqi Hospital,Key Laboratory of Cancer Prevention and Treatment in Heilongiiang Province,Mudanjiang 157011,China)
出处 《肿瘤研究与临床》 CAS 2018年第8期565-568,共4页 Cancer Research and Clinic
基金 国家自然科学基金(81271628)
关键词 甲状腺肿瘤 乳头状 基因 Thyroid neoplasms Carcinoma papillary Genes
  • 相关文献

参考文献4

二级参考文献26

  • 1朱晓丽,周晓燕,朱雄增.甲状腺乳头状癌中BRAF^(V599E)点突变与RET/PTC融合基因的检测[J].中华病理学杂志,2005,34(5):270-274. 被引量:30
  • 2翁阳,高子芬,刘侃,张伟京,克小燕,李敏.弥漫性大B细胞淋巴瘤预后相关因素的研究[J].中华内科杂志,2005,44(9):681-683. 被引量:10
  • 3朱晓丽,周晓燕,张太明,朱雄增.野生型RET和RET/PTC融合基因在成人散发性甲状腺乳头状癌中的表达及其意义[J].中华病理学杂志,2006,35(2):87-91. 被引量:4
  • 4Annitage JO,Weisenburger DD.New approach to classifying non-Hodgkin's lymphomas:clinical features of the major histologic subtypes.Non-Hodgkin's Lymphoma Classification Project.J Clin Oncol,1998,16:2780-2795.
  • 5Cheson BD.Hematologic malignancies:new developments and future treatments.Semin Oncol,2002,29:33-45.
  • 6Vogelstein B,Lane D,Levine AJ.Surfing the p53 network.Nature,2000,408:307-310.
  • 7Abramson JS,Shipp MA.Advances in the biology and therapy of diffuse large B-cell lymphoma:moving towards a molecularly targeted approach.Blood,2005,106:1164-1174.
  • 8Hans CP,Weisenburger DD,Greiner TC,et al.Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.Blood,2004,103:275-282.
  • 9Farinha P,Sehn L,Skinnider B,et al.Strong p53 expression is an independent predictor of outcome in de novo diffuse large B-cell lymphoma (DLBCL) treated with either CHOP or CHOP-R.Blood,2006,108:244a.
  • 10Young KH,Leroy K,Moller MB,et al.Structural profiles of Tp53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma:an international collaborative study.Blood,2008,112:3088-3098.

共引文献28

同被引文献66

引证文献9

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部